![]() Other isotype antibodies (IgA, IgG1-4) were also detected. ![]() SARS-CoV-2 Spike protein or Nucleocapsid protein specific IgG antibodies at titers more than 1:100,000 were detectable in all PCR+ subjects ( nā=ā115) and were absent in the negative controls. We developed highly sensitive SARS-CoV-2-specific antibody and neutralization assays. ![]() Development of antibody protection during SARS-CoV-2 infection is a pressing question for public health and for vaccine development. ![]()
0 Comments
Leave a Reply. |